- Grants since 2016
- 484
- Awarded, last 5 years (where amounts are published)
- 57M
- Funded works, last 5 years
- 437
- Funded works, all time
- 2 006
Grants
2018–2020 · award
Targeting TDP-43 pathology in C9ORF72-mediated ALS
Xin Jiang
2018–2021 · award
Expanded population of regulatory T-Cells (EPAR T-Cells) for people with Amyotrophic Lateral Sclerosis
Stanley Appel
2017–2018 · award
Maintain the SOD1 breeding colony in 2017
Taconic Biosciences
2017–2021 · award
Dissecting the link between cytoskeletal disruption and mRNA processing in ALS
Claudia Fallini
2017–2020 · award
Phase 2 trial of inosine in ALS
Sabrina Paganoni
2017–2020 · award
The ALS Online Genetics Database, ALSoD
Ammar Al-Chalabi
2017–2019 · award
Identifying therapeutics for ALS using ALS-linked mutant Profilin-1
Anthony Giampetruzzi
2017–2018 · award
2017 Sheila Essey Award given in recognition of outstanding achievements in ALS research
John Ravits
2017–2019 · award
Project MinE
Jonathan Glass
2017–2019 · award
Selection of a novel target clinical candidate for the treatment of ALS
Antonella Favit-Vanpelt
2017–2018 · award
Identifying molecular targets to enhance muscle innervation in Amyotrophic Lateral Sclerosis
Sandrine Da Cruz
2017–2019 · award
ALS on a Chip
Clive Svendsen
2017–2018 · award
Tag-free axonal translatome of mouse models of ALS/FTD to reveal defects in axonal mRNA transport and association to axonal polysomes.
Gabriella Viero
2017–2021 · award
Tethering cysteine pairs with cyclic disulfides: a method for stabilizing fALS SOD1 variants
Jeffrey Agar
2017–2018 · award
Countering TDP-43, FUS, and dipeptide repeat protein toxicity with engineered Hsp104 variants.
Meredith Jackrel
2017–2019 · award
Identifying determinants of FUS nucleocytoplasmic localization by CRISPR/Cas9 genetic screen in ALS patient cells
Nibha Mishra
2017–2021 · award
Identification of novel biomarkers for C9ORF72-linked diseases, combining a targeted approach with an unbiased screen
Marka Van Blitterswijk
2017–2021 · award
HERV-K Molecular studies in Amylotrophic Lateral Sclerosis
Adele Mccormick
2017 · award
Disruption of TDP-43 granule assembly by ALS mutations
Nicolas Fawzi
2017–2020 · award
CDNF and CDNF variants - novel therapy for ALS
Mart Saarma
2017–2019 · award
Project MinE
John Landers
2017–2019 · award
Combating ER stress in G85R ALS mice
Raymond Roos
2017–2020 · award
TDP-43 splicing repression as a therapeutic target for ALS
Philip Wong
2017–2019 · award
Targeting proteotoxicity as the common denominator in ALS
Jiou Wang
2017–2019 · award
Cervical spine imaging and CSF neurofilament light chain as biomarkers in patients with Amyotrophic Lateral Sclerosis
Nicholas Olney
2017–2020 · award
RAN translation of hexanucleotide repeats in C9ORF72-ALS/FTD
Shuying Sun
2017–2020 · award
Drosophila models of ubiquilin-associated ALS
Randal Tibbetts
2017–2020 · award
Ameliorating TDP-43-associated pathogenesis with global transcriptional perturbations
Timothy Lu
2017–2019 · award
Development of RNA-templated small molecules to treat C9 ALS/FTD
Yue Li
2017–2019 · award
Utilizing Telehealth technologies to manage the ALS patient
Stephen Selkirk
2017–2018 · award
EMG communication and control device
Dexter Ang
2017–2021 · award
Neurofilament assay
Markus Otto
2017–2021 · award
ALS Association - Neuro Collaborative - identification and validation of therapeutic targets and developments of therapeutics for ALS
Steve Finkbeiner
2017–2021 · award
How disturbance in stress granule dynamics is converted into TDP-43 pathology
J. Taylor
2017–2019 · award
Linking TDP43 pathology with stress granule dynamics
Maria Purice
2017–2020 · award
A Voice for People with ALS
Peter Desain
2017–2021 · award
NLY01: A GLP-1 analog for the treatment of ALS
Nicholas Maragakis
2017–2018 · award
Trans-cellular transmission of misfolded TDP-43 and ALS Progression
Don Cleveland
2017–2021 · award
Preclinical development of KPT-350 for C9-ALS
Thomas Lloyd
2017–2021 · award
Development of a clinically relevant outcome measure for ALS therapeutic trials
Chad Heatwole